Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.
about
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerMouse models of prostate cancer: picking the best model for the question.Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity.Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transitionCancer stem cell plasticity and tumor hierarchy.Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.A Unique Expression of Keratin 14 in a Subset of Trophoblast CellsPten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.Prostate cancer stem cells: The case for model systemsAnimal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors.Recent progress in mouse models for tumor suppressor genes and its implications in human cancer.Molecular pathogenesis and progression of prostate cancerPrimary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines.MicroRNAs and epithelial-mesenchymal transition in prostate cancer.Proliferative and nonproliferative lesions of the rat and mouse male reproductive system.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcomeCabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer.An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesis.ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer.Biology and evolution of poorly differentiated neuroendocrine tumors.Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.Sphere-Formation Assay: Three-Dimensional Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
P2860
Q28771715-A8B98BB0-0035-4FA5-A806-F954803D16AEQ33940867-8DFB81BB-91FF-4BE9-A1A1-529E953541ABQ34056013-6D2EA5D1-08F0-43BD-893D-EDD86A02E032Q34243311-1B34194D-5CDC-443E-9944-DE50A6667911Q34459650-0DF8B58D-3EC9-41A7-80BF-CB862AE43C34Q34624405-9A3D0651-5ECD-4FC2-B618-04D2CA6C3290Q35796688-830E7C06-861B-4B47-85C2-EEDC2A9FCC48Q35871737-E8BB1E92-D38B-41C1-ABF3-C268D3AAAEE8Q35890704-B62B9F85-A994-400A-B2E8-118799F5DFBFQ36815316-C86378D7-8C50-4EF0-B7FF-C4AB2BB4C985Q36825219-B5C63E9A-5E99-47F6-B035-EB0CBF74B899Q36929407-AC8E8C07-4224-45B3-8B83-1E0375F7425BQ37055715-43D0FF42-34ED-4510-8F1D-B79D34D7A746Q37301718-10038369-4560-4A04-B329-7DE166EB4CADQ37687205-491B000F-57C9-48AB-BF0B-C31503F68287Q38040759-9655929D-044A-4E0E-80DA-22D2168F001AQ38203779-A7747835-991A-47E0-9D40-7843398C7EC2Q38824007-5F923C86-2D95-4B71-8DD8-A376EF5CB203Q38919780-BB0FB28D-FD2D-461D-B4D9-FB6DB801A628Q38926353-300D95B3-BD02-4175-A16E-D09882D7D05FQ39037653-057FA1B9-0F50-413A-885E-B2D8692B3939Q39634850-2339F80A-B77F-4E24-8FC6-C4CC616C6497Q40888865-054BB801-FA4E-4084-932B-F968AD046142Q41874830-B9CF61CF-77A1-4465-A577-68B0538A5377Q42049451-593776F0-0914-4958-AC14-051DF8718EB7Q46269336-614403B6-384F-415B-A433-33E3DABED4B6Q48320507-7A8216E8-F051-4EC2-A4AD-E92CA4092161Q48363650-23E1738A-B506-46AA-B378-E2D40536D320Q49887950-2BBB6DF6-8F3A-4323-A4C8-7F7C3457DEC3Q58698021-A63B6CE7-EA83-46B9-A01B-15585C1473AC
P2860
Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Prostate epithelial Pten/TP53 ...... ial to mesenchymal transition.
@ast
Prostate epithelial Pten/TP53 ...... ial to mesenchymal transition.
@en
type
label
Prostate epithelial Pten/TP53 ...... ial to mesenchymal transition.
@ast
Prostate epithelial Pten/TP53 ...... ial to mesenchymal transition.
@en
prefLabel
Prostate epithelial Pten/TP53 ...... ial to mesenchymal transition.
@ast
Prostate epithelial Pten/TP53 ...... ial to mesenchymal transition.
@en
P2093
P2860
P1476
Prostate epithelial Pten/TP53 ...... ial to mesenchymal transition.
@en
P2093
Daniel Camacho
Kathleen Kelly
Orla Casey
Philip Martin
R Mark Simpson
Rachel Pierce
Victoria Seng
Wassim Abou-Kheir
Yen-Nien Liu
P2860
P304
P356
10.1016/J.AJPATH.2011.03.035
P407
P577
2011-05-13T00:00:00Z